Microsoft Corp (MSFT)
Volume
NA
Market Cap
NA
52 Week High
NA
52 Week Low 
NA
Supplied by Morningstar Inc
Earnings Release FY13 Q4
Cash Flows Statements (in millions)
Year Ended June 30, 2013 2012 2011
Operations
Net income $ 21,863 $ 16,978 $ 23,150
Adjustments to reconcile net income to net cash from operations:
Goodwill impairment 0 6,193 0
Depreciation, amortization, and other 3,755 2,967 2,766
Stock-based compensation expense 2,406 2,244 2,166
Net recognized losses (gains) on investments and derivatives 80 (200) (362)
Excess tax benefits from stock-based compensation (209) (93) (17)
Deferred income taxes (19) 954 2
Deferral of unearned revenue 44,253 36,104 31,227
Recognition of unearned revenue (41,921) (33,347) (28,935)
Changes in operating assets and liabilities:
Accounts receivable (1,807) (1,156) (1,451)
Inventories (802) 184 (561)
Other current assets (129) 493 (1,259)
Other long-term assets (478) (248) 62
Accounts payable 537 (31) 58
Other current liabilities 146 410 (1,146)
Other long-term liabilities 1,158 174 1,294
Net cash from operations 28,833 31,626 26,994
Financing
Short-term debt repayments, maturities of 90 days or less, net 0 0 (186)
Proceeds from issuance of debt 4,883 0 6,960
Repayments of debt (1,346) 0 (814)
Common stock issued 931 1,913 2,422
Common stock repurchased (5,360) (5,029) (11,555)
Common stock cash dividends paid (7,455) (6,385) (5,180)
Excess tax benefits from stock-based compensation 209 93 17
Other (10) 0 (40)
Net cash used in financing (8,148) (9,408) (8,376)
Investing
Additions to property and equipment (4,257) (2,305) (2,355)
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets (1,584) (10,112) (71)
Purchases of investments (75,396) (57,250) (35,993)
Maturities of investments 5,130 15,575 6,897
Sales of investments 52,464 29,700 15,880
Securities lending payable (168) (394) 1,026
Net cash used in investing (23,811) (24,786) (14,616)
Effect of exchange rates on cash and cash equivalents (8) (104) 103
Net change in cash and cash equivalents (3,134) (2,672) 4,105
Cash and cash equivalents, beginning of period 6,938 9,610 5,505
Cash and cash equivalents, end of period $ 3,804 $ 6,938 $ 9,610
 
Related Information
FY14 Earnings Release Schedule
IMPORTANT NOTICE TO USERS (summary only, click here for full text of notice); All information is unaudited unless otherwise noted or accompanied by an audit opinion and is subject to the more comprehensive information contained in our SEC reports and filings. We do not endorse third-party information. All information speaks as of the last fiscal quarter or year for which we have filed a Form 10-K or 10-Q, or for historical information the date or period expressly indicated in or with such information. We undertake no duty to update the information. Forward-looking statements are subject to risks and uncertainties described in our Forms 10-Q and 10-K.